About: Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $96.54 (-0.28%)
DNTH NASDAQ Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. share price
DNTH price activity
Last Price
$96.540
Change (24hr)
-0.27 USD (-0.28%)
Volume
585.40K
Volume (4w avg)
-
Open
$95.95
Day Range
$94.58 - $99.61
Previous Close
$96.81
Last Trade
21 Sep, 8:00 pm GMT+0
Delayed
21 Sep, 8:00 pm GMT+0
DNTH price performance
Delayed
21 Sep, 8:00 pm GMT+0
DNTH Market Signals